Abstract
One of the most challenging areas in the field of peptide science is the chemistry of cysteine and the need for multiple protecting groups that can be removed orthogonally to facilitate regioselective disulfide bond formation. This article reviews the methods and reagents used to remove the various protecting groups of cysteine derivatives with subsequent disulfide bond formation used in peptide synthesis. Also reviewed is the related amino acid selenocysteine, which requires benzyl-type protecting groups during synthesis. As these benzyl groups are difficult to remove using older methods, we highlight the use of electrophilic, aromatic disulfides for the removal of selenocysteine (and cysteine) protecting groups with concomitant disulfide and diselenide bond formation.
Keywords: Cysteine, selenocysteine, protecting groups, deprotection, peptides
Mini-Reviews in Organic Chemistry
Title: Cysteine and Selenocysteine Deprotection Chemistry in Peptide Synthesis
Volume: 6 Issue: 3
Author(s): Stevenson Flemer Jr.
Affiliation:
Keywords: Cysteine, selenocysteine, protecting groups, deprotection, peptides
Abstract: One of the most challenging areas in the field of peptide science is the chemistry of cysteine and the need for multiple protecting groups that can be removed orthogonally to facilitate regioselective disulfide bond formation. This article reviews the methods and reagents used to remove the various protecting groups of cysteine derivatives with subsequent disulfide bond formation used in peptide synthesis. Also reviewed is the related amino acid selenocysteine, which requires benzyl-type protecting groups during synthesis. As these benzyl groups are difficult to remove using older methods, we highlight the use of electrophilic, aromatic disulfides for the removal of selenocysteine (and cysteine) protecting groups with concomitant disulfide and diselenide bond formation.
Export Options
About this article
Cite this article as:
Flemer Jr. Stevenson, Cysteine and Selenocysteine Deprotection Chemistry in Peptide Synthesis, Mini-Reviews in Organic Chemistry 2009; 6 (3) . https://dx.doi.org/10.2174/157019309788922748
DOI https://dx.doi.org/10.2174/157019309788922748 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Copanlisib: Novel PI3K Inhibitor for the Treatment of Lymphoma
Anti-Cancer Agents in Medicinal Chemistry Vaccination Against SARS-CoV-2 Protects from COVID-19-induced Endothelial Dysfunction
Current Pharmaceutical Design The Induction of Proinflammatory Cytokines in Response to Avian Influenza H5N1 Infections and their Role in Pathogenesis and the Enhancement of Virulence
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Davis-Beirut Reaction: A Novel Entry into 2H-indazoles and Indazolones. Recent Biological Activity of Indazoles
Mini-Reviews in Medicinal Chemistry Assessment of the Mitotic Spindle Assembly Checkpoint (SAC) as the Target of Anticancer Therapies
Current Cancer Drug Targets Subject Index to Volume 1
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Synthesis of 2-Thiohydantoins as Somatostatin Subtype 4 Receptor Ligands
Letters in Drug Design & Discovery Permeability for Intestinal Absorption: Caco-2 Assay and Related Issues
Current Drug Metabolism Chemoinfectomics in Drug Design and Development
Anti-Infective Agents An Update on Natural Occurrence and Biological Activity of Chromones
Current Medicinal Chemistry Chemistry and Pharmacology of Angiotensin-Converting Enzyme Inhibitors
Current Pharmaceutical Design REVIEWER ACKNOWLEDGEMENT
Current Pharmacogenomics and Personalized Medicine Unequivocal Role of Pyrazine Ring in Medicinally Important Compounds: A Review
Mini-Reviews in Medicinal Chemistry Pharmacologic Activities of 5, 6-Diaryl/heteroaryl-3-substituted-1, 2, 4- triazines as a Privileged Scaffold in Drug Development
Mini-Reviews in Medicinal Chemistry Aging and Remodeling During Healing of the Wounded Heart: Current Therapies and Novel Drug Targets
Current Drug Targets Discovery and Design of Selective Cyclooxygenase-2 Inhibitors as Non-Ulcerogenic, Anti-Inflammatory Drugs with Potential Utility as Anti-Cancer Agents
Current Drug Targets Structure-Based Discovery of PDEs Inhibitors
Current Topics in Medicinal Chemistry Natural Products as Farnesoid X Receptor (FXR) Agonists: Their Interactions with FXR Ligand Binding Region
Mini-Reviews in Organic Chemistry 3D-QSAR and Docking Studies of 4-morpholinopyrrolopyrimidine Derivatives as Potent mTOR Inhibitors
Letters in Drug Design & Discovery Molecular Properties Prediction, Docking Studies, and Antimicrobial Screening of 1,3,4-Thiadiazole and s-Triazole Derivatives
Current Computer-Aided Drug Design